Curative Therapies for Sickle Cell Disease.

Conclusion: Evaluation of the long-term benefits of curative therapies for SCD requires comparative clinical trials and studies of late effects. PMID: 31258425 [PubMed]

https://www.ncbi.nlm.nih.gov/pubmed/31258425?dopt=Abstract

Source: Ochsner Journal - July 3, 2019 Category: General Medicine Tags: Ochsner J Source Type: research